Multivalent Antibacterial Monoclonal Antibodies ( (Immunethep))

N/A

Report date: 2025/04/01 11:31:22

Base Information

Drug NameMultivalent Antibacterial Monoclonal Antibodies ( (Immunethep))
Drug Alias NameUNImAb
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStreptococcus Agalactiae InfectionPneumococcal InfectionsStaphylococcal Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugal
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunethep SA
China Registration ClassN/A

Develop Information

Active CompaniesImmunethep SA
Inactive CompaniesN/A
Active IndicationsStreptococcus Agalactiae InfectionPneumococcal InfectionsStaphylococcal Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A